Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 243
1 161 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
AbbVie Inc
ABBV
|
$264.46 |
+0.2%
|
$467.2B |
|
|
|
Amgen Inc
AMGN
|
$385.72 |
+1.6%
|
$208.2B |
|
|
|
Gilead Sciences, Inc
GILD
|
$150.83 |
0%
|
$187.3B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$509.435 |
-1.3%
|
$129.3B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$787.52 |
-0.2%
|
$82.6B |
|
|
|
argenx SE
ARGX
|
€871.4 |
+0.4%
|
$62.5B |
|
|
|
Moderna Inc
MRNA
|
$154.195 |
-2.5%
|
$61.2B |
|
|
|
CSL Ltd
CSL
|
AU$175.59 |
-1.1%
|
$59.8B |
|
|
|
Natera Inc
NTRA
|
$362.4 |
-1.1%
|
$51.9B |
1 156 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account